Encephalopathy future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
Newer investigational and therapeutic modalities are under review.
Newer investigational and therapeutic modalities are being investigated.


==New Therapies==
==New Therapies==
* Newer modalities of treatment are considered for [[hypoxic encephalopathy]].  These drugs reduce the brain activity and its oxygen requirement.
Newer modalities of treatment are considered for [[hypoxic encephalopathy]].  These drugs reduce the brain activity and its oxygen requirement.
** Magnesium - blocks NMDA receptor
* Magnesium - blocks NMDA receptor
** Adenosine - decreases glutamate release
* [[Adenosine]] - decreases glutamate release
** Vitamin C - reduces free radicals
* [[Vitamin C]] - reduces free radicals
** Caspase inhibitors - Inhibit apoptosis and prevents death of brain tissue
* [[Caspase inhibitors]] - Inhibit [[apoptosis]] and prevents death of brain tissue


==References==
==References==
Line 17: Line 17:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Grammar]]

Revision as of 11:11, 24 July 2012

Encephalopathy

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Encephalopathy from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Electroencephalogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Encephalopathy future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Encephalopathy future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Encephalopathy future or investigational therapies

CDC on Encephalopathy future or investigational therapies

Encephalopathy future or investigational therapies in the news

Blogs on Encephalopathy future or investigational therapies

Directions to Hospitals Treating Encephalopathy

Risk calculators and risk factors for Encephalopathy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Newer investigational and therapeutic modalities are being investigated.

New Therapies

Newer modalities of treatment are considered for hypoxic encephalopathy. These drugs reduce the brain activity and its oxygen requirement.

References

Template:WH Template:WS